Y Intercept Hong Kong Ltd Invests $862,000 in SPDR S&P Biotech ETF $XBI

Y Intercept Hong Kong Ltd bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 6,746 shares of the exchange traded fund’s stock, valued at approximately $862,000.

Other institutional investors have also added to or reduced their stakes in the company. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $256,053,000. Wells Fargo & Company MN increased its position in shares of SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp raised its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after buying an additional 1,187,907 shares in the last quarter. Morgan Stanley raised its holdings in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after buying an additional 882,718 shares in the last quarter. Finally, Assetmark Inc. lifted its position in SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $159.03 on Monday. The company has a market capitalization of $10.76 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The business has a 50 day moving average of $140.41 and a 200 day moving average of $131.41. SPDR S&P Biotech ETF has a 1-year low of $84.39 and a 1-year high of $165.71.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.